“The River Cities team has been insightful and supportive throughout the challenges of launching a new business and the subsequent rapid growth of our company. They understand the key elements of successful strategy, collaboration and the art of getting things done. River Cities is an extremely valuable partner to our company,” says Mark Gilreath, CEO, EndoChoice.
River Cities Capital Funds has announced the sale of MedPlast, Inc., a River Cities Fund IV portfolio company, to Water Street Healthcare Partners and JLL Partners.
New capital will fuel commercial real estate technology pioneer’s continued innovation and expansion.
To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees.
The company has 21 facilities in Arkansas, Mississippi and Tennessee and plans to use the $35 million debt and equity investment from Crestline Investors to develop new facilities and make an acquisition.